McDermott Welcomes Kristian Werling as New Leader in Global Health & Life Sciences Practice

McDermott Will & Emery Elevates Krist Werling to Head Health & Life Sciences

In a significant move within the healthcare legal sector, McDermott Will & Emery, an esteemed international law firm, has appointed Kristian (Krist) Werling as the global head of its distinguished Health & Life Sciences Practice Group. This practice group is well-respected, consisting of over 160 lawyers across 20 locations worldwide, making it the largest and most skilled of its kind among U.S. law firms. The group has held an impressive position, being ranked as Band 1 by Chambers for 15 consecutive years, denoting its outstanding reputation and effectiveness in the industry.

McDermott's commitment to excellence in this field is underscored by its consistent ranking at the top of PitchBook's League Tables, demonstrating its active role in representing private equity investors in healthcare. "Krist is an extraordinary partner, leader, and mentor… he delivers the best possible results—and always with a collaborative approach," said Ira Coleman, Chairman of McDermott. This commendation reflects not only Krist’s proficiency but also the firm’s confidence in his capabilities as he transitions into this key leadership role.

Before this appointment, Krist Werling was co-head of the firm’s private equity practice and an elected member of its Management Committee. His extensive experience makes him well-equipped to steer the Health & Life Sciences team. In his legal practice, he has represented a myriad of clients including life sciences companies, health service providers, private equity firms, and venture capital investors on various transactional and regulatory issues. His leadership aligns with the innovative trajectory of McDermott’s Health & Life Sciences practice, which has achieved groundbreaking industry transactions that exemplify excellence. These initiatives include the launch of cancer and gene therapy products in global markets, enhancing fertility services, and increasing the availability of cost-effective outpatient surgical services.

In 2024, Krist played a vital role in significant transactions, such as representing Valinor Pharma in its acquisition by Grünenthal and assisting Amulet Capital Partners with its platform investment in Theoria Management, LLC. His track record of success is indicative of his strategic thinking and ability to navigate complex deals within the healthcare sector.

Expressing his enthusiasm for his new role, Krist said, "I’m honored to lead such a talented and globally recognized team… The health and life sciences sectors are rapidly evolving, and I look forward to helping our clients achieve their strategic goals and drive innovation in these critical industries." This statement highlights Krist’s commitment to advancing the practice and providing exceptional counsel to clients navigating the dynamic healthcare landscape.

McDermott Will & Emery stands as a leader in healthcare and life sciences law in the United States, equipping clients with superior strategies for complex healthcare challenges. The firm boasts robust cross-border capabilities and top-tier teams across Europe. Its approach includes organizing various healthcare-focused events that foster significant interactions among clients, facilitating business relationships and opportunities. Additionally, clients gain more value from the firm’s affiliation with McDermott+, which directs healthcare policy and advocacy efforts, assisting them in maneuvering through legislative and regulatory hurdles to achieve business prosperity.

The firm’s prestigious healthcare practice has not only been recognized by Chambers but also holds top rankings from other notable publications like Best Law Firms, Legal 500, LMG Life Sciences, and Law360. This wide-ranging acclaim solidifies McDermott's reputation in an ever-evolving sector where legal expertise is crucial.

In conclusion, Krist Werling’s appointment heralds a new chapter for the Health & Life Sciences Practice Group at McDermott Will & Emery. His strategic vision and experience will undoubtedly continue to promote the firm’s leadership in the healthcare sector, ensuring that they remain at the forefront of legal services in this vital field.